{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JHO0dkIDA","lastupdate":"2022-12-06T00:00:00.000Z","update_date":"2022-12-06T00:00:00.000Z","lastModified":"Mar 3, 2025","active":1,"confidence_score":98,"confidence_score_reason":"funding rounds, markets","urlname":"aid-genomics","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$HEM044NBk4Js8UFCaXyUetW5QDaFPjhpUTwZRNS3HU9G7b3kMigONh","name":"AID Genomics","oneliner":"Early Detection and Personalized Treatment of Cancer and Infectious Diseases ","registrar":"515882884","website":"https://www.aidgenomics.com/","careerspage":"","founded_month":7,"founded_year":2018,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"https://www.facebook.com/AID-Genomics-115066810237463","linkedin":"https://www.linkedin.com/company/33242362","instagram":""},"social":["https://www.linkedin.com/company/33242362","https://www.facebook.com/AID-Genomics-115066810237463"],"flattenedsociallinks":"https://www.linkedin.com/company/33242362|https://www.facebook.com/AID-Genomics-115066810237463","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"51-200","employees_exact":52,"patent":1,"raised":0,"stage":"Pre-Funding","public_stage":"Pre-Funding","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["GeneSort","AID-Genomics","AID.Genomics","AIDTES","A.I.D Genomics","AIDGenomics","AID Partners"],"about":"AID Genomics is a research and development-driven diagnostic company focused on the development of precision medicine-based diagnostic solutions primarily for oncology, hereditary rare diseases, and infectious diseases.\n‍\nOne of its primary goals is to enable patients around the world to access more accurate diagnostics and to ensure physicians have the diagnostic tools and data they need to make better therapy recommendations to patients.\nIts rich research and development division combines cutting-edge technologies such as next-generation sequencing, miRNA, and epigenetics, alongside AI-based analytical tools. The company's strong and diverse partnerships help deliver affordable precision medicine that will improve patients' care and quality of life.\n‍\nAID Genomics is a member of the AID Private Equity Group.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97286290999","country":null,"address":{"israeli":[{"id":"6bc719a2-545d-4483-ad1c-1581702d4066","city":"Rehovot","type":null,"address":"Prof. Menahem Plaut Street 10, Rehovot, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"f34f5f93-a09b-4526-8269-c2c0aac1bd15","city":null,"address":"Hong Kong","country":"Hong Kong","placeid":null}]},"headquarter_address":null,"district":"Center District","news":[{"id":"eo3KMoDal8V1a0PzIMHBM4sZP0Pvy5q2jW3bn8MCk8GYlG1XldQRmI","date":"Jul 24, 2022","link":"https://www.calcalist.co.il/calcalistech/article/sj8849q3q","source":"www.calcalist.co.il","visible":1,"analysis":{"tags":"diagnostics, layoffs","company":"AID GENOMICS","layoffs":400,"summary":"AID GENOMICS, an international diagnostics company with a significant presence in Israel, has announced the suspension of its research and development activities and the termination of planned investments in Israel. As part of the process, the company is laying off 400 employees in Israel, leaving only 150 employees to continue working under a contract with the Ministry of Health. AID GENOMICS specializes in genetic diagnostics, early diagnosis, and treatment of diseases. The company has been involved in providing COVID-19 testing solutions and has supported multiple countries, including Israel, with millions of test kits. The CEO of AID GENOMICS expressed frustration with the Ministry of Healths delays and stated that the company has suffered significant financial losses.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["AID GENOMICS","COVID-19 testing","Partnership","Investment","Layoffs"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-negative","investment_amount":null,"structured_issues":["Layoffs"],"acquisition_amount":null,"structuredIssuesShow":"#Layoffs","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"growth-negative","analysisId":"j8CIPix4mWtAQQ7elUQdGx06OC8zNVlt7fClwQvhDLVSEl4Fc7vl54","news_summary":"חברת Aid Genomics סוגרת פעילות מחקר ופיתוח ומפטרת 400 עובדים בארץ | כלכליסט","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"SijeEciEIXPhuEeqEevQgFwFUWNIXwOSqb56H9OSKwUqFdd2v8TUIc","date":"Jun 27, 2022","link":"https://www.ynet.co.il/health/article/r1tfa1d5c","source":"www.ynet.co.il","visible":1,"analysis":{"tags":"COVID-19 testing","company":"AID Genomics","layoffs":null,"summary":"Israeli company AID Genomics has developed a digital kiosk for self-administered PCR testing for COVID-19. The kiosk allows individuals to perform the test in front of a camera without the need for professional sampling or appointments. The samples are then sent to a laboratory for processing. The development of the kiosk could save millions of shekels if testing at Ben Gurion Airport resumes. The company is in talks with airports and pharmacy chains worldwide for the deployment of the kiosks. The cost of testing using the kiosk is significantly lower than traditional methods. The pilot testing showed a 100% success rate. The kiosks have already been introduced in branches of Good Pharm and Lametayel in Israel.","partners":"Good Pharm, Lametayel","customers":null,"investors":null,"confidence":8,"key_topics":["Digital kiosk","PCR testing","Cost-saving","Partnerships","Expansion"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"2JsBtXcsOdZKPZ7oa34pwwsyTPUMDevJqvTbBKMbmhG88mL2L2THGH","news_summary":"חדש בישראל: קיוסק דיגיטלי לבדיקת קורונה עצמית שיחסוך למדינה כסף רב","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"289a5257-24dd-47fb-8eb0-2e8efff3c83a","date":"Dec 28, 2021","link":"https://bloomer.co.il/%D7%AA%D7%97%D7%95%D7%9D-%D7%99%D7%99%D7%A6%D7%95%D7%90-%D7%97%D7%93%D7%A9-%D7%9C%D7%99%D7%A9%D7%A8%D7%90%D7%9C-aid-genomics-%D7%9E%D7%A7%D7%99%D7%9E%D7%94-%D7%91%D7%90%D7%A4%D7%A8%D7%99%D7%A7%D7%94/?_atscid=7_134353_204082920_2078924_0_Txtetaxjxdshwhus8sp","source":"bloomer.co.il","visible":1,"analysis":{"tags":"Expansion, Investment","company":"AID GENOMICS","layoffs":"N/A","summary":"Israeli diagnostics company AID GENOMICS has signed a deal in Africa and is in talks with other countries for deals worth tens of millions of dollars. The company has invested tens of millions of dollars in research and development in 2021 to cope with the rapid changes in the pandemic patterns. AID GENOMICS is leading a new export field by establishing new laboratories abroad where advanced and innovative technologies will be implemented. The company has decided to move most of its operations abroad due to the spread of the Omicron variant and multiple requests from governments, companies, and private bodies around the world.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":8,"key_topics":"Diagnostics, Coronavirus, Expansion, Africa, Research and Development","date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"Tens of millions of dollars","structured_issues":"Investment, Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Investment, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"HKB385LerYdY7YGW4K6vmoA8fRoV3CDSGV4AyHJo2cFAdBuIFaTEex","news_summary":"תחום ייצוא חדש לישראל: AID GENOMICS מקימה באפריקה מעבדות לזיהוי נגיף הקורונה  בלומר","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"2edf636c-9a2e-4deb-bc73-7694af87c216","date":"Dec 28, 2021","link":"https://www.jpost.com/israel-news/article-689888","source":"www.jpost.com","visible":1,"analysis":{"tags":"expansion","company":"AID Genomics","layoffs":null,"summary":"AID Genomics, Israels leading coronavirus testing company, has signed a deal to set up laboratories for detecting and genetic sequencing of the virus in Africa. The company plans to expand its operations into Africa, Europe, Asia, and North America. AID Genomics will redistribute its resources and reduce the activity of its corona testing division in Israel. The company was founded in 2018 and focuses on developing precision medicine-based diagnostics for oncology, rare diseases, and infectious diseases. It has been contracted by the government to provide COVID-19 PCR testing and operates the largest coronavirus lab in the Middle East region. Despite expanding abroad, AID Genomics will maintain its research and development division in Israel.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["coronavirus testing","genetic sequencing","Africa","expansion","precision medicine"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"uk3l4BgfNJfaKoc5EoJk7GeCEWQyPxJf8P2VfnvmPrJ8tDXifB7DTf","news_summary":"https://www.jpost.com/israel-news/article-689888","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4ca06eb2-9c09-4277-8798-d6d349c5650f","date":"Oct 11, 2021","link":"https://www.globes.co.il/news/article.aspx?did=1001386808","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Partnership, Expansion","company":"AID GENOMICS","layoffs":"N/A","summary":"Israeli genetics company AID GENOMICS has donated a complete laboratory for coronavirus testing to Kazakhstan. The donation includes advanced equipment and training for local teams. The lab, established in Shymkent in close collaboration with Kazakhstans National Center of Expertise (NCE) and with the assistance of the Israeli embassy in Kazakhstan, has the capacity to process thousands of coronavirus tests per day. This significant contribution will aid the countrys efforts to combat the spread of the Delta variant of the coronavirus.","partners":"National Center of Expertise (NCE), Israeli embassy in Kazakhstan","customers":"N/A","investors":"N/A","confidence":9,"key_topics":"Coronavirus Testing, Laboratory Donation","date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Partners, Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Partners, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"9kqBsocnbuPzzKs8AWzUPlx8CISgZRoSd0ppCmUh5aeaPVF4e0I0qt","news_summary":"החברה הישראלית שתעזור לקזחסטן להיאבק בקורונה","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4c5e7179-f773-4964-947f-0f9513254799","date":"Sep 27, 2020","link":"https://www.jpost.com/israel-news/israeli-diagnostic-company-partners-with-aid-genomics-on-covid-19-testing-643701","source":"www.jpost.com","visible":1,"analysis":{"tags":"partnership, COVID-19 testing","company":"Todos Medical Ltd.","layoffs":null,"summary":"Todos Medical Ltd. has entered into an implementation and equipment financing partnership with AID Genomics for COVID-19 testing. AID Genomics will finance the purchase of equipment needed to meet capacity requirements and help Todos speed up scaling and optimizing sample accessioning and data reporting software. AID Genomics will also receive part of the net profit of each contract and assist Todos in validating and commercializing proprietary tests in Israel. This partnership will allow Todos to pursue new laboratory equipment and reagent supply agreements to meet the increasing testing needs in the US. Todos Medical is an Israeli company that develops testing for the early detection of various cancers and has distribution agreements for COVID-19 tests. AID Genomics has worked with Israels Health Ministry to build six HMO labs in Israel.","partners":["AID Genomics"],"customers":null,"investors":null,"confidence":9,"key_topics":["COVID-19 testing","partnership","equipment financing","PCR testing capacity","diagnostic solutions"],"date_of_event":"September 27, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"pKEdd1CtZETsM3ERJm1jQKEb4Jrc5fulPFy4whKODBsvAwJo9KP2Db","news_summary":"https://www.jpost.com/israel-news/israeli-diagnostic-company-partners-with-aid-genomics-on-covid-19-testing-643701","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"bb5f8705-0cd4-4654-93bd-74d3fb7a5ff1","date":"Jul 19, 2020","link":"https://www.jpost.com/health-science/rapid-corona-test-could-save-israels-hospitals-enable-gathering-again-635504","source":"www.jpost.com","visible":1,"analysis":{"tags":"COVID-19 testing","company":"AID Genomics","layoffs":null,"summary":"Israeli company AID Genomics has developed a PCR testing kit that can determine if a person is infected with SARS-CoV-2 in less than two hours. The low-cost test can be performed by paramedics and is more sensitive than other kits, requiring less RNA and amplification time. The company aims to use the test to enable the reopening of events, theaters, and other spaces where large crowds gather. The kit has not yet received regulatory approval but will be submitted for review worldwide in the next two weeks. AID Genomics hopes to have the kit on the market by the fall.","partners":["BGI Group"],"customers":null,"investors":null,"confidence":8,"key_topics":["PCR testing kit","COVID-19","Israels hospitals","large events","regulatory approval"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"pXshuSreQSv7R9JvFqVnGyRfp1SBcj0M1qKhNBxtix1yJKIxb0Ayzv","news_summary":"https://www.jpost.com/health-science/rapid-corona-test-could-save-israels-hospitals-enable-gathering-again-635504","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"f65b8ea5-4b36-4c0f-ae5f-5aa8834d49b4","date":"Jul 8, 2020","link":"https://www.timesofisrael.com/30-minute-covid-19-test-developed-in-israel-inventor-predicts-it-will-go-global/","source":"www.timesofisrael.com","visible":1,"analysis":{"tags":"coronavirus test kit","company":"AID Genomics","layoffs":null,"summary":"Israeli company AID Genomics has developed a half-hour coronavirus test kit that is predicted to become a globally available screening solution. The company has changed the enzymes and components used in test kits to enable faster processing times. The kits are expected to have similar accuracy levels as existing kits but at a significantly lower cost. The kit is currently awaiting approval from regulators, including the US Food and Drug Administration. AID Genomics hopes that the innovation will help various industries, such as concert venues and sports stadiums, to carry out screening upon arrival and return to normal operations. AID Genomics has a partnership with the Chinese-owned BGI Group for coronavirus-related projects.","partners":"BGI Group","customers":null,"investors":null,"confidence":8,"key_topics":["coronavirus test kit","screening solution","processing tests","cheaper than existing express services","partnership with BGI Group"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"RUo58bRVUoNOTIPaBXGA6WbOT9KglJS1sXkVC0p8BQRIFItlVyAWl2","news_summary":"30-minute COVID-19 test developed in Israel;inventor predicts it will go global","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"986df453-2527-4fd1-b636-e58d132ae179","date":"Apr 6, 2020","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3806418,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"partnership","company":"AID Genomics Ltd.","layoffs":null,"summary":"AID Genomics Ltd. and Beijing Genomics Institute (BGI) have partnered to open a laboratory in Gaza for conducting up to 3,000 coronavirus tests per day. The Palestinian Authority has approved the plans and technology transfer. Mammoth Foundation has donated funds for the lab. AID Genomics was acquired by Aid Partners Capital Holdings for $23 million in 2017. BGI, founded in 1999, currently employs 6,000 people. Last week, MyHeritage Ltd. announced a partnership with BGI to open a coronavirus testing lab in Israel, but the plans were frozen by Israels Ministry of Health.","partners":["Beijing Genomics Institute (BGI)"],"customers":null,"investors":"Aid Partners Capital Holdings","confidence":9,"key_topics":["coronavirus testing","laboratory","partnership","technology transfer","donation"],"date_of_event":"2020-04-06","valuation_amount":"$23 million","impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"MmBA7V6c0cFzeEXK5pNTdNrsuHFajvzzg5gGKWiSFAHd1sev75xIkk","news_summary":"AID Genomics and China's BGI to Open Covid-19 Testing Lab in Gaza","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":9,"events":null,"techcommunityinvolvement":null,"mediagallery":[{"id":"91cf1d9e-46d1-494e-8803-68816e82bc0d","timestamp":"2020-07-09 08:58:22.000000","resources_type":2,"resources_title":"AID Genomics Genesort Explanatory video","resources_file_name":"qQviE3X9xfw","alt":"AID Genomics Genesort Explanatory video logo","imageurl":"https://img.youtube.com/vi/qQviE3X9xfw/0.jpg","url":"http://youtu.be/qQviE3X9xfw"},{"id":"fb08590e-95c6-43e2-8552-e480f573172c","timestamp":"2020-07-09 08:44:54.000000","resources_type":2,"resources_title":"AID GENOMICS lab solution","resources_file_name":"o0Bw0gz6DRE","alt":"AID GENOMICS lab solution logo","imageurl":"https://img.youtube.com/vi/o0Bw0gz6DRE/0.jpg","url":"http://youtu.be/o0Bw0gz6DRE"}],"tags":["patients","genomics","digital-healthcare","diagnostics","cancer","bioinformatics","personalization","biotechnology","personalized-medicine","treatments","early-detection"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":[],"geomarkets":["Africa"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":0,"lastfunding":"Undisclosed","totalrounds":0,"fundingstage":"Pre-Funding","totalfunding":"Undisclosed","publicinvestors":0,"lastpublicfunding":null,"totalpublicrounds":0,"totalpublicfunding":0},"team":[{"name":"Snir Zano","email":"snir@aidgenomics.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4NHy8aULDA","bounced":true,"claimed":0,"founder":0,"urlname":"snir-zano-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgwdWtvQsM","position":"Group CEO","last_name":"Zano","claimtoken":"U78ehnvIjMb5lo4a4N8i0VGvQfMbj77MFKZmx3OoafN3hgnJ0YrCdV","first_name":"Snir","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/snir-zano-062641a4/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-12-06 15:31:09.000000","initials":"SZ","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Dor Sultan","email":"dor@aidgenomics.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4MHVgpQIDA","bounced":false,"claimed":1,"founder":0,"urlname":"dor-sultan","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg0eP6hwkM","position":"COO","last_name":"Sultan","claimtoken":"6cd6b515944a835547f0e0f2452c8e3ad73cdc7a4c13cbe3647c79081f370437","first_name":"Dor","picturekey":"$cvNZMWyaXLsStGIno5wH4cK7yVqV4d3lPn3vYqcFjmXNNS3pCSGUWi","claimeddate":"2020-07-09","linkedinurl":"https://www.linkedin.com/in/dor-sultan-23108982/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-07-09 10:33:02.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$cvNZMWyaXLsStGIno5wH4cK7yVqV4d3lPn3vYqcFjmXNNS3pCSGUWi","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Izhak Haviv","email":"izhak@aidgenomics.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4KGTv6kIDA","bounced":false,"claimed":0,"founder":0,"urlname":"izhak-haviv","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg4Z2j2QkM","position":"Chief Scientist","last_name":"Haviv","claimtoken":"fhdQKnk4ikrsohBVdOJHCFMAuEPYPv8ItwpeIWK4GziYkefBXzbakj","first_name":"Izhak","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/izhak-haviv-a1079a20/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-12-06 15:31:05.000000","initials":"IH","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-10-05T00:00:00.000Z","crunchbaseid":"aidgenomics","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Jenny Sotnik-Talisman","creator_email":"genys30@yahoo.com","createdate":"2020-07-09T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":null,"affiliatedOrganizations":null,"timeline":[],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"7/2018","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"AID Genomics","logourl":"https://storage.googleapis.com/clean-finder-353810/$HEM044NBk4Js8UFCaXyUetW5QDaFPjhpUTwZRNS3HU9G7b3kMigONh","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$HEM044NBk4Js8UFCaXyUetW5QDaFPjhpUTwZRNS3HU9G7b3kMigONh","seoabout":"AID Genomics is a research and development-driven diagnostic company focused on the development of precision medicine-based diagnostic solutions primarily ...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Digital Medical Diagnostics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Genes","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationDelimited":["TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA>Genes#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Digital Medical Diagnostics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA"],"classificationsViewModel":"|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|2:>TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA/Genes#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Digital Medical Diagnostics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Digital Healthcare","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare","children":[{"title":"Digital Medical Diagnostics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Digital Medical Diagnostics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Patients","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals","children":[{"title":"Genes","key":"0-0-0","path":"TechnologyClassificationModel>Biologicals>Genes"}]},{"title":"Artificial Intelligence","key":"0-1","path":"TechnologyClassificationModel>Artificial Intelligence"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Digital Medical Diagnostics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":2,"name":"Genes","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvztpMKDA","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Digital Healthcare","Digital Medical Diagnostics"],"coreTechnology":["Biologicals","Genes","Artificial Intelligence"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Patients"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}